Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). [electronic resource]
Producer: 20100601Description: 1371-1377.e1 p. digitalISSN:- 1879-1913
- Adult
- Blood Chemical Analysis
- C-Reactive Protein -- analysis
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Echocardiography
- Female
- Follow-Up Studies
- Hospitals, University
- Humans
- Inflammation Mediators -- analysis
- Injections, Subcutaneous
- Interleukin 1 Receptor Antagonist Protein -- administration & dosage
- Interleukin-1 -- analysis
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Myocardial Infarction -- complications
- Pilot Projects
- Probability
- Reference Values
- Risk Assessment
- Treatment Outcome
- Ventricular Dysfunction, Left -- prevention & control
- Ventricular Remodeling -- drug effects
- Virginia
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.